← All journal posts
Founder letter6 min read

Why we built YOAKE: the pharmacy shelf I missed every time I left Tokyo

A founder's letter on the second shelf of every Lawson cooler, the cold-chain freight math that keeps these bottles off US shelves, and why the reservation model is the point — not a workaround.

By YOAKE team

The idea for YOAKE is the same fridge in every Japanese convenience store. Second shelf from the bottom, under the cold coffee and next to the jelly drinks. A dozen brown bottles of Hepalyse W, a row of Ukon no Chikara's aluminum cans, a stack of Lipovitan D. A category that in Japan is simply called "liver drinks" (肝臓ドリンク), sold at every Lawson, Family Mart, and 7-Eleven across 125 million people, every single day.

You fly home from Tokyo and it is gone. Not hard to find — gone. You can pay a 3× parallel-import markup on Amazon, or wait for your next trip.

We spent a year figuring out why.

The answer is boring: cold-chain freight economics.

A single pallet of Hepalyse W from Osaka to LAX via cold-chain air freight costs a fixed amount — roughly $3,000 — regardless of whether the pallet is full or half-empty. A full pallet carries around 1,500 bottles, which makes the freight cost per bottle reasonable. A half-empty pallet makes it prohibitive.

Most small importers pick "charge more." Which is why the re-sellers sell Hepalyse for $8 per bottle when it is ¥250 in a Japanese konbini. The markup is not greed. It is the honest cost of moving small quantities across an ocean under temperature control.

So you need scale. And to get scale pre-launch, you need commitment before inventory. Which is the reservation model.

The reservation mechanic, in plain English

When you reserve, we authorize your card. No money moves. Every Sunday at 23:59 JST, we close the reservation window. If we clear the cold-chain freight minimum (currently 150 full-shelf equivalents), we capture the authorizations Monday morning and hand the purchase order to our Japan fulfillment partner. If we do not hit the minimum, every authorization is voided — you pay nothing, and the window reopens the following week.

This is not crowdfunding. It is not a Kickstarter. It is a demand-test mechanism engineered for a specific supply-chain constraint: Japan Airlines does not fly a cold-chain cargo slot for 30 bottles. So we set a floor.

The honest version: this model really only matters for the first run, when there is no cash to risk on a half-full pallet. Once the first shipment lands and we have inventory turns to borrow against, the reservation window becomes less load-bearing. But it stays. It is a forcing function against over-ordering.

Why these four products and not others

Japan's wellness OTC shelves have thousands of SKUs. We picked four that answer four different jobs.

Hepalyse W (Zeria, line since 1968, W variant since 2011) — the classic. A liver-support drink with enzyme-hydrolysed pork liver extract and curcumin. The "adult, slightly serious" choice on the konbini shelf. Every salaryman over 35 has had one in the last month.

Ukon no Chikara (House Foods, 2004) — the modern one. A turmeric beverage built around curcumin and House's proprietary bisacuron compound. Aluminum bottles, approachable brand, sold out of the same cooler as Hepalyse.

Alpitan (Kobayashi) — the traditional one. Kobayashi's retail packaging of Goreisan (五苓散), a five-herb Kampo formula that dates back to a Chinese medical text compiled around 200 CE and remains part of Japan's regulated traditional medicine system.

Lipovitan D (Taisho, 1962) — the energy one. The first mass-market taurine drink, 25 years before Red Bull. 1,000 mg taurine, 50 mg caffeine, brown glass, unchanged formula.

Four categories, four makers, one shelf. That is the thesis.

What we are not

We do not make claims about what these products do in the body. We do not use the word "cure." We do not market these as anything more than what the Japanese labels say they are. All four are classified in the US as dietary supplements and functional beverages, and none of them are approved or evaluated by the FDA for any medical purpose. Usage guidance comes from the Japanese product label.

What we do is import the actual Japanese retail pack, flown cold-chain from Osaka, with a small English supplement-facts overlabel applied at our US fulfillment partner for FDA compliance. That is the product. The claim is: this is what is sold in Japan, and we will get it to you without changing it.

If that is not enough of a pitch, we are not the right brand for you. There are more aggressive companies in the category making bigger promises. We will compete on honesty, pack integrity, and getting the actual Japanese thing to your door.

What happens next

Reservation window one opens this week. If it clears, the first shipment leaves Osaka on Monday morning JST, clears US customs at LAX, and reaches continental-US addresses by Thursday. Every shipment's manifest, lot number, and temperature log goes up on the archive page the week it leaves — even shipments where something goes wrong.

If it doesn't clear, we extend, post about why, and go back to the thing that matters most: being the right first brand for anyone who has already spent time on that cold konbini fridge shelf.

— The YOAKE team